Providing actionable real-world evidence to support patients, clinicians, and policymakers in decision making.
CREST develops real-world evidence on the health effects of medications and other medical products, and prepares the next generation of pharmacoepidemiology leaders.
Explore the latest research from CREST investigators.
A new Penn study introduces the first cardiovascular risk model built specifically for people who use stimulants, offering clinicians a practical tool to identify high-risk patients early.
A new publication from Sean Hennessy examines how climate change influences medication use and highlights opportunities to build more resilient and sustainable healthcare systems.
Carmen E. Guerra is a co-author of the latest American Cancer Society colorectal cancer screening guideline, which introduces new screening options and updates recommendations for average-risk adults.
Sean Hennessy, PharmD, PhD, co-authored a new publication examining limitations in current cardiovascular disease risk prediction methods and the need for more precise approaches to improve accuracy and equity across diverse populations.